Results: 48
COVID-19 Vaccine-induced antibody response to BNT162b2 mRNA in frontline healthcare workers.
- Published in:
- Revista Salud UIS, 2024, v. 56, p. 1, doi. 10.18273/saluduis.56.e:24034
- By:
- Publication type:
- Article
A Computable Phenotype Algorithm for Postvaccination Myocarditis/Pericarditis Detection Using Real-World Data: Validation Study.
- Published in:
- Journal of Medical Internet Research, 2024, v. 26, p. 1, doi. 10.2196/54597
- By:
- Publication type:
- Article
Data mining of adverse drug event signals with Nirmatrelvir/Ritonavir from FAERS.
- Published in:
- PLoS ONE, 2024, v. 19, n. 12, p. 1, doi. 10.1371/journal.pone.0316573
- By:
- Publication type:
- Article
The incidence of COVID-19 infection following emergency use authorization of BBIBP-CORV inactivated vaccine in frontline workers in the United Arab Emirates.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-021-04244-1
- By:
- Publication type:
- Article
FDA issues Emergency Use Authorization to Yale School of Public Health for SalivaDirect, which uses a new method of saliva sample processing.
- Published in:
- Rhode Island Medical Journal, 2020, v. 103, n. 7, p. 91
- Publication type:
- Article
Comparison of regulatory approval system for medicines in emergency among Japan, the United States, the United Kingdom, Europe, and China.
- Published in:
- PLoS ONE, 2024, v. 19, n. 9, p. 1, doi. 10.1371/journal.pone.0309992
- By:
- Publication type:
- Article
The role of hesitancy and infrastructure in the equity and efficiency of COVID-19 vaccine administration.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0304416
- By:
- Publication type:
- Article
A rapid, low-cost, and highly sensitive SARS-CoV-2 diagnostic based on whole-genome sequencing.
- Published in:
- PLoS ONE, 2023, v. 18, n. 11, p. 1, doi. 10.1371/journal.pone.0294283
- By:
- Publication type:
- Article
Editorial: What does experimental pharmacology and drug discovery look like in 2035?
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1504817
- By:
- Publication type:
- Article
Vela Diagnostics Receives FDA Emergency Use Authorization for Zika Virus Molecular Assay.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, n. 1, p. ii
- By:
- Publication type:
- Article
Response to Several Recent Publications Related to Safety and Efficacy of Peramivir From the Emergency Use Authorization Experience.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Emergency Use Authorization for Intravenous Peramivir: Evaluation of Safety in the Treatment of Hospitalized Patients Infected With 2009 H1N1 Influenza A Virus.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. 1, p. 1, doi. 10.1093/cid/cis351
- By:
- Publication type:
- Article
Peramivir Use for Treatment of Hospitalized Patients With Influenza A(H1N1)pdm09 Under Emergency Use Authorization, October 2009–June 2010.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. 1, p. 8
- By:
- Publication type:
- Article
Editorial Commentary: What Did We Learn From the Emergency Use Authorization of Peramivir in 2009?
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices -United States, 2024–2025.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2024, v. 73, n. 37, p. 819, doi. 10.15585/mmwr.mm7337e2
- By:
- Publication type:
- Article
Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices -- United States, September 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 42, p. 1140, doi. 10.15585/mmwr.mm7242e1
- By:
- Publication type:
- Article
Outcomes and Healthcare Resource Utilization in Patients with COVID-19 Treated with Nirmatrelvir–Ritonavir: Real-World Data Analysis.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 20, p. 6091, doi. 10.3390/jcm13206091
- By:
- Publication type:
- Article
A case report of severe hyponatremia secondary to Paxlovid‐induced SIADH.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Extraction-Free Detection of SARS-CoV-2 Viral RNA Using LumiraDx's RNA Star Complete Assay from Clinical Nasal Swabs Stored in a Novel Collection and Transport Medium.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 18, p. 3010, doi. 10.3390/diagnostics13183010
- By:
- Publication type:
- Article
A Systematic Review of Nirmatrelvir/Ritonavir and Molnupiravir for the Treatment of Coronavirus Disease 2019.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 9, p. 1, doi. 10.1093/ofid/ofae497
- By:
- Publication type:
- Article
Low Prevalence of Nirmatrelvir-Ritonavir Resistance-Associated Mutations in SARS-CoV-2 Lineages From Botswana.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 7, p. 1, doi. 10.1093/ofid/ofae344
- By:
- Publication type:
- Article
Efficacy and Safety of Low-Dose, Rapidly Infused Bamlanivimab and Etesevimab: Phase 3 BLAZE-1 Trial for Mild-to-Moderate COVID-19.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 10, p. 2123, doi. 10.1007/s40121-024-01031-z
- By:
- Publication type:
- Article
Clinical Pathology Evaluation in Pet Rabbits Vaccinated Against Rabbit Hemorrhagic Disease Virus 2 (RHDV2).
- Published in:
- Animals (2076-2615), 2024, v. 14, n. 20, p. 3029, doi. 10.3390/ani14203029
- By:
- Publication type:
- Article
COVID-19 Vaccines: Where Did We Stand at the End of 2023?
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 2, p. 203, doi. 10.3390/v16020203
- By:
- Publication type:
- Article
Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 1, p. 112, doi. 10.3390/v16010112
- By:
- Publication type:
- Article
A review of clinical efficacy data supporting emergency use authorization for COVID‐19 therapeutics and lessons for future pandemics.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 10, p. 2279, doi. 10.1111/cts.13384
- By:
- Publication type:
- Article
Molnupiravir in Combination With Nirmatrelvir/Ritonavir: No Cause for Alarm.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 6, p. 1297, doi. 10.1093/infdis/jiae214
- By:
- Publication type:
- Article
Public and health care provider attitudes, understanding, and behaviors regarding emergency use authorizations: a scoping literature review.
- Published in:
- BMC Public Health, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12889-024-20234-0
- By:
- Publication type:
- Article
Dosing recommendation of nirmatrelvir/ritonavir using an integrated population pharmacokinetic analysis.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 12, p. 1897, doi. 10.1002/psp4.13039
- By:
- Publication type:
- Article
Deriving M-polynomial Based Topological Descriptors of Oral Antiviral Clinical Drug Nirmatrelvir.
- Published in:
- Scientific Annals of Computer Science, 2024, v. 34, n. 2, p. 113, doi. 10.47743/SACS.2024.2.113
- By:
- Publication type:
- Article
Changing views toward mRNA based covid vaccines in the scientific literature: 2020-2024.
- Published in:
- Polish Annals of Medicine, 2024, v. 31, n. 2, p. 1, doi. 10.29089/paom/189961
- By:
- Publication type:
- Article
Diverse Parents Decision-Making to Vaccinate Their Child under Five Attending Childcare Programs.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 8, p. 2299, doi. 10.3390/jcm13082299
- By:
- Publication type:
- Article
Emergency use authorization of medicines: History and ethical dilemma.
- Published in:
- Perspectives in Clinical Research, 2023, v. 14, n. 2, p. 49, doi. 10.4103/picr.picr_149_22
- By:
- Publication type:
- Article
FDA to Hold Advisory Committee Meetings to Discuss Emergency Use Authorization for Booster Doses and COVID-19 Vaccines for Younger Children.
- Published in:
- Neonatology Today, 2021, v. 16, n. 10, p. 127
- By:
- Publication type:
- Article
Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine.
- Published in:
- Neonatology Today, 2020, v. 15, n. 12, p. 96
- By:
- Publication type:
- Article
Impact of variable titer COVID-19 convalescent plasma and recipient SARS-CoV2-specific humoral immunity on survival in hospitalized patients.
- Published in:
- PLoS ONE, 2024, v. 19, n. 10, p. 1, doi. 10.1371/journal.pone.0309449
- By:
- Publication type:
- Article
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 4, p. 1, doi. 10.1371/journal.ppat.1011680
- By:
- Publication type:
- Article
The Emergency Use Authorization of Pharmaceuticals: History and Utility During the COVID-19 Pandemic.
- Published in:
- Pharmaceutical Medicine, 2021, v. 35, n. 4, p. 203, doi. 10.1007/s40290-021-00397-6
- By:
- Publication type:
- Article
Emergency Use Authorization (EUA) to Enable Use of Needed Products in Civilian and Military Emergencies, United States.
- Published in:
- Emerging Infectious Diseases, 2007, v. 13, n. 7, p. 1046, doi. 10.3201/eid1307.061188
- By:
- Publication type:
- Article
Efficacy and Cardiovascular Safety of Remdesivir in COVID-19: A Case-Control Study.
- Published in:
- Journal of Young Pharmacists, 2023, v. 15, n. 4, p. 716, doi. 10.5530/jyp.2023.15.98
- By:
- Publication type:
- Article
Current approach on COVID-19 for Emergency Use Authorization in Europe: Sotrovimab.
- Published in:
- Journal of Young Pharmacists, 2022, v. 14, n. 4, p. 372, doi. 10.5530/jyp.2022.14.75
- By:
- Publication type:
- Article
Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Planning Considerations and Lessons Learned From a COVID-19 Mass Community Vaccination Center.
- Published in:
- Military Medicine, 2022, v. 187, n. 1/2, p. 17, doi. 10.1093/milmed/usab303
- By:
- Publication type:
- Article
Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients—authors' response.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 12, p. 3360, doi. 10.1093/jac/dkae357
- By:
- Publication type:
- Article
COVID‐19 vaccine hesitancy linked to increased internet search queries for side effects on fertility potential in the initial rollout phase following Emergency Use Authorization.
- Published in:
- Andrologia, 2021, v. 53, n. 9, p. 1, doi. 10.1111/and.14156
- By:
- Publication type:
- Article
Vaccine hesitancy cannot be considered in a vacuum.
- Published in:
- Industrial Psychiatry Journal, 2024, v. 33, n. 2, p. 208, doi. 10.4103/ipj.ipj_105_24
- By:
- Publication type:
- Article
International assessment results on non-NIOSH approved respirators by the national personal protective technology laboratory (NPPTL): a data note.
- Published in:
- BMC Research Notes, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13104-024-06800-0
- By:
- Publication type:
- Article
Emergency-use authorization of peramivir.
- Published in:
- American Journal of Health-System Pharmacy, 2009, v. 66, n. 24, p. 2162, doi. 10.2146/ajhp090584
- By:
- Publication type:
- Article